Here are relevant reports on : energy-supplement-market
-
Creatine Supplement Market
The Creatine Supplement Market is witnessing robust growth globally, driven by the increasing awareness of sports nutrition and the rising adoption of fitness and bodybuilding activities. Creatine, a naturally occurring compound found in muscle cells, is widely used in dietary supplements to enhance athletic performance, muscle strength, and recovery.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Chicory Market by Product Type (Extracts, Roasted, Instant Powder, Flour), Form (Powder, Cubes, Liquid), Plant Part, Application (Food & Beverage, Dietary Supplement, Feed & Pet food, Cosmetics & Personal Care), and Region - (2020 - 2025)
The chicory market size was estimated to be valued at USD 685 million in 2020 and is projected to reach USD 905 million by 2025, recording a CAGR of 5.7%. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Cosucra Groupe Warcoing (Belgium), Delecto Foods Pvt Ltd (India), BENEO GmbH (Germany), Sensus (Netherlands), Leroux (France), Cargill Incorporated (US), Reily Foods Company (US), Pioneer Chicory (India), PMV Nutrient Products Pvt Ltd (India), Farmvilla Food Industries Pvt Ltd (India), Murlikrishna Foods Pvt Ltd (India), Starwest Botanicals (US), STOKROS Company Ltd (Russia), Nature’s Gold Production (Netherlands), Organic Herb Trading Co (UK), Narasu’s Coffee Company (India), NP Nutra (US), Shaanxi Sciphar Natural Product Co Ltd. (China), Jamnagar Chicory Industries (India), and Herbs & Crops Overseas (India).
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
Pet Supplements Market by Functional Application (Skin & Coat, Hips & Joints, Digestive Health, Immune Support), Supplement Type (Multivitamin, Glucosamine, Antioxidants), Pet, Form, Distribution Channel, and Region - Global Forecast to 2029
According to MarketsandMarkets, the global pet supplements market is estimated to be valued at USD XXX.X million in 2024 and is projected to reach USD XXX.X million by 2029, recording a CAGR of X.X%. Key players in this market include ADM (US), Nestlé (Switzerland), Nutramax Laboratories, Inc. (US), Zoetis Services LLC (US), Virbac (France), Zesty Paws (US), These players have adopted strategies of product launches, expansions, agreements/partnerships, and mergers and acquisitions to grow in the market. All key product manufacturers that are part of the pet supplements ecosystem have been considered under the company profiles section.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Europe Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics, Synbiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Europe Human Microbiome Market, valued at US$0.22 billion in 2024, stood at US$0.29 billion in 2025 and is projected to advance at a resilient CAGR of 28.6% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. The growth of the Europe human microbiome market is driven by increased awareness of personalized health, the adoption of microbiome-based therapies, and advancements in sequencing technologies and bioinformatics.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Precision Nutrition Market by Technology (Metabolomics, Genomics, Transcriptomics, Proteomics), Application (Disease Management, General Health & Wellness, Weight Management), Service Type, End-Use, Supplement, and Region - Global Forecast to 2029
The market for precision nutrition is projected to reach USD 12.89 billion by 2029, at a CAGR of 16.2% during the forecast period. The report profiles key players such as Viome Life Sciences, Inc. (US), Prenetics Global Limited (China), ZOE Limited (UK), myDNA Life Australia Pty Ltd. (Australia) , 23andMe, Inc. (US), DayTwo Inc (US), Nutrigenomix (Canada), Genesis Healthcare Co. (Japan), AMILI (Singapore), and SelfDecode (US).
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Beta-Glucan Market by Category (Soluble, Insoluble), Source (Cereal & Grains, Mushroom, Yeast, Seaweed), Application (Food & Beverage, Dietary Supplement, Personal Care, Cosmetics, Pharmaceuticals, Animal Feed), Type and Region - Global Forecast to 2029
The beta-glucan market size is projected to reach USD 800 million by 2029; it is projected to grow at a CAGR of 8.1% during the forecast period. Tate & Lyle PLC (UK), Kerry Group plc (Ireland), dsm-Firmenich (Switzerland), Merck (Germany), Lesaffre (France), Kemin Industries (US), Angel Yeast Co. Ltd. (China), Lallemand (Canada), Associated British Foods Plc (UK), Bigrigin (Brazil), Ceapro, Inc. (Canada), NutriScience Innovations, LLC (US), Alltech (US), Garuda International Inc. (US), and Leiber (Germany) are the key players in the beta glucan market.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Asia Pacific Human Microbiome Market, valued at US$0.19 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. Market growth is driven by an increasing focus on preventive and personalized health, rising adoption of microbiome-based diagnostics and therapeutic solutions, and rapid advances in next-generation sequencing, AI-enabled microbiome analytics, and regional bioinformatics capabilities.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Ketones Market by Application (Supplements, Food & Beverages, Cosmetics & Personal Care Products), Supplement Type (Ketone Salts, Ketone Esters, Ketone Oils, Raspberry Ketones), Form (Solid, Liquid, Semi- Liquid) and Region - Global Forecast to 2029
The global ketones market is witnessing significant growth, with an estimated value projected to reach USD 818.9 million by 2029 from the 2024 valuation of USD 594.9 million, indicating a substantial Compound Annual Growth Rate (CAGR) of 6.6%. Key players in this market include Perfect Keto Group (US), H.V.M.N. INC. (US), KetoLogic (US), Pruvit Ventures, Inc. (US), and KetoneAid (US). Companies are focusing on expanding their production facilities, entering into partnerships as well as agreements, and launching new products to grow their business and, in turn, their market share.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Supplement Testing Market by Test Type (Identity/Authentication, Potency, Contaminants, Microbiological, and Others), Product Tested (Ingredients and Finished Products), Technology, End-use, Service Provider, and Region – Global Forecast to 2030
The dietary supplements testing market is estimated at USD 2,400.0 million in 2025 and is projected to reach USD 3,652.2 million by 2030, at a CAGR of 8.8%. The report profiles key players such as Eurofins Scientific (Luxembourg), SGS Société Générale de Surveillance SA (Switzerland), Intertek Group plc (UK), Mérieux NutriSciences (US), UL Solutions (US), TÜV SÜD (Germany), ALS (Australia), Tentamus (Italy), Agrolab Group (Germany), FoodChain ID (US), Certified Laboratories (US), Element Materials Technology (UK), NSF (US), Vimta Labs Ltd. (India), Qalitex (US), Alkemist (US), and Anresco Laboratories (US).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
- Published: September 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
